Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.

被引：0
|
作者：
Faustman, Denise L.
Torrey, Heather
Butterworth, John
Mera, Toshi
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Warden, Sara
Plager, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd
    Vargas, Juan Gamboa
    Kanzler, Carla
    Scheller, Lukas
    Kreckel, Jennifer
    Shaikh, Haroon
    Lang, Isabell
    Medler, Juliane
    Anany, Mohamed
    Steinfatt, Tim
    Hartweg, Julia
    Haack, Stefanie
    Holler, Ernst
    Buettner-Herold, Maike
    Gaviria, Paula Tabares
    Wajant, Harald
    Beilhack, Andreas
    Einsele, Hermann
    BLOOD, 2022, 140 : 4465 - 4466
  • [12] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rahbar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [13] Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies
    Torrey, Heather
    Defusco, Audrey
    Baum, Danielle
    Rhabar, Ziba
    Khodadoust, Michael
    Kim, Youn H.
    Faustman, Denise L.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [14] Direct oncogene cancer killing and selective tumor Treg killing through the TNFR2 receptor via dominant antibody antagonists
    Torrey, Heather
    Butterworth, John
    Mera, Toshi
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Warden, Sarah
    Plager, Sara
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [15] Novel TNFR2 humanized mouse model for human TNFR2 antibody evaluation
    Guo, Yanan
    Li, Yanan
    Zhou, Xiaofei
    Su, Youhong
    Lin, Qingcong
    CANCER RESEARCH, 2020, 80 (16)
  • [16] The role of tumor necrosis factor receptor 2 (TNFR2) in EAE
    Arena, Maria Montes De Oca
    Bartsch, Brenden
    Schwegman, Lance
    Abdul-Baki, Nawal
    Forsthuber, Thomas
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [17] Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2
    Tanimura, Y
    Kokuryo, T
    Tsunoda, N
    Yamazaki, Y
    Oda, K
    Nimura, Y
    Mon, NN
    Huang, PY
    Nakanuma, Y
    Chen, MF
    Jan, YY
    Yeh, TS
    Chiu, CT
    Hsieh, LL
    Hamaguchi, M
    CANCER LETTERS, 2005, 219 (02) : 205 - 213
  • [18] MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2
    Jiang, Mengmeng
    Yang, Yang
    Niu, Liling
    Li, Ping
    Chen, Yibo
    Liao, Ping
    Wang, Yifei
    Zheng, Jingbin
    Chen, Fengyang
    He, Huanhuan
    Li, Hui
    Chen, Xin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
  • [19] Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment.
    Sum, Chi Shing
    Danton, Makenzie
    Hu, Qihui
    Pritsker, Alla
    Lin, Ray
    Yu, Raymond
    Chen, Kevin
    Tang, Fangqiang
    Pohl, Thomas
    Wallner, Samantha
    Hassan, Ahmed
    Lu, Huarui
    Huang, Haichun
    Pei, James
    Liu, Zhong
    Li, Han
    Lei, Ming
    CANCER RESEARCH, 2021, 81 (13)
  • [20] Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
    Li, Muchun
    Zhang, Xiaozhen
    Bai, Xueli
    Liang, Tingbo
    FRONTIERS IN ONCOLOGY, 2022, 12
12345